Baxter International BAX Pharmaceuticals — Currency translation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's pharmaceuticals — currency translation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's pharmaceuticals — currency translation?
- Baxter International (BAX) reported pharmaceuticals — currency translation of -$8M in Q1 2026.
- How has Baxter International's pharmaceuticals — currency translation changed year-over-year?
- Baxter International's pharmaceuticals — currency translation decreased by 147.1% year-over-year, from $17M to -$8M.
- What does pharmaceuticals — currency translation mean?
- The financial impact caused by changes in foreign currency exchange rates on segment performance.
- How do you interpret pharmaceuticals — currency translation?
- A positive value indicates a favorable currency tailwind, while a negative value indicates a headwind impacting reported segment earnings.
- How does pharmaceuticals — currency translation compare across companies?
- Standard for multinational healthcare companies with significant non-domestic revenue streams.